Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK-453,061), in healthy adult subjects

Lignende værker

• No effect of a single supratherapeutic dose of lersivirine, a next-generation NNRTI, on QTc interval in healthy subjects
  af: Vourvahis, M, et al.
  Udgivet: (2010)
• Effect of Rifampin and Rifabutin on the Pharmacokinetics of Lersivirine and Effect of Lersivirine on the Pharmacokinetics of Rifabutin and 25-O-Desacetyl-Rifabutin in Healthy Subjects
  af: Vourvahis, Manoli, et al.
  Udgivet: (2012)
• Pharmacokinetic Effects of Coadministration of Lersivirine with Raltegravir or Maraviroc in Healthy Subjects
  af: Vourvahis, Manoli, et al.
  Udgivet: (2012)
• No Effect of a Single Supratherapeutic Dose of Lersivirine, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, on Corrected QT Interval in Healthy Subjects
  af: Vourvahis, Manoli, et al.
  Udgivet: (2012)
• Lersivirine: a new NNRTI active across HIV-1 subtypes with a unique resistance profile
  af: Mori, J, et al.
  Udgivet: (2010)